Tute Genomics Inc.

Financings During the final quarter of 2015, start-up companies raised a total of $2.41 billion, $156 million less than the previous quarter but a 65% increase from Q4 2014's total of $1.46 billion. F

IN VITRO DIAGNOSTICS Alliances Dentamed Ltd. Diamedica Ltd. SIRAM Ltd. Vigilant Biosciences Inc. Vigilant Biosciences Inc. signed three new multi-year distribution agreements for marketing of its

FDA's decision to grant a 23andMe Inc. carrier-screening test marketing access opens up new possibilities for the company and for the broader direct-to-consumer genetic test market much sooner tha

FDA's decision to grant a 23andMe Inc. carrier-screening test marketing access opens up new possibilities for the company and for the broader direct-to-consumer genetic test market much sooner tha